Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Contemporary Treatment Patterns and Clinical Outcomes of Comorbid Diabetes Mellitus and HFrEF

JACC Heart Failure(2020)10.1016/j.jchf.2019.12.015Source: DataRank Database

Contemporary Treatment Patterns and Clinical Outcomes of Comorbid Diabetes Mellitus and HFrEF is a research paper published in JACC Heart Failure (2020). On theSindex it has a DataRank of 0. It has been cited 85 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

85 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (23 grants)Impact (FWCI 6.78)OA: closedTopics (61)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Gregg C. Fonarow ORCID,Stephen J. Greene ORCID,Adam D. DeVore ORCID,Abhishek Kavati ORCID,Slaven Sikirica ORCID

Live enrichment

PubMed:32387066 OpenAlex:https://openalex.org/W3022116511

GlaxoSmithKline

Janssen Pharmaceuticals

Amgen

Medtronic

National Heart, Lung, and Blood Institute

Patient-Centered Outcomes Research Institute

Duke Clinical Research Institute

European Commission

National Center for Advancing Translational Sciences

American Regent

AstraZeneca

Bristol-Myers Squibb

Boehringer Ingelheim

Boston Scientific Corporation

Luitpold Pharmaceuticals

Novartis

Abbott Laboratories

American Heart Association

Bayer Fund

Cytokinetics

Merck

Novartis Pharmaceuticals Corporation

National Institutes of Health

FWCI

6.78

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

closedLicense: http://www.elsevier.com/open-access/userlicense/1.0/

publisherhttps://api.elsevier.com/content/article/PII:S2213177920300950?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2213177920300950?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jchf.2019.12.015

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32387066

Fields of Study

Diabetes Treatment and ManagementHyperglycemia and glycemic control in critically ill and hospitalized patientsDiabetes Management and ResearchAdrenergic beta-AntagonistsAgedAngiotensin Receptor AntagonistsAngiotensin-Converting Enzyme InhibitorsComorbidityDiabetes MellitusFemaleFollow-Up StudiesGuideline AdherenceHeart FailureHumansMaleMiddle AgedMineralocorticoid Receptor AntagonistsOutpatientsProspective StudiesRegistriesStroke VolumeTime FactorsTreatment Outcome

MeSH Terms

Adrenergic beta-AntagonistsAgedMineralocorticoid Receptor AntagonistsAngiotensin-Converting Enzyme InhibitorsDiabetes MellitusFemaleFollow-Up StudiesHeart FailureHumansMaleMiddle AgedOutpatientsProspective StudiesRegistriesStroke VolumeTime FactorsComorbidityTreatment OutcomeGuideline AdherenceAngiotensin Receptor Antagonists

Keywords

MedicineInternal medicineDiabetes mellitusInterquartile rangeValsartanHeart failureContext (archaeology)Dipeptidyl peptidase-4 inhibitorAngiotensin receptorEndocrinologyEjection fractionType 2 Diabetes MellitusCardiologyAngiotensin IIReceptorBlood pressureClinical OutcomesGuideline-directed Medical Therapy

Sustainable Development Goals

SDG 0: Good health and well-being

Contemporary Treatment Patterns and Clinical Outcomes of Comorbid Diabetes Mellitus and HFrEF

FAIR Checklist

Authors (15)

Funding (23 grants)

Impact

Open Access

Topics